-
DUBAI, United Arab Emirates - A pharmaceutical company from the Kurdistan Region is attending the International Conference of Pharmacy & Exhibition Event (ICPM), the largest healthcare exhibition in Dubai, along with 130 global pharmaceutical companies, aiming to export and promote its products to the Gulf countries.
“We have more than 200 types of [pharmacutical] products that are available from both the private and public sectors and we can distribute them throughout Iraq. We are proud to participate in this conference and be able to import our medicine alongside Arab and international companies,” Aram Mohammed, a doctor and marketing director of Awamedica, told Rudaw.
"Our goal at this conference is to be enrolled in the [Gulf] market, and we have sent supplements to Syria and Yemen, and other countries," Ruha Jarjish, a sales officer at Awamedica, told Rudaw.
In addition to exhibiting the products of the pharmaceutical companies, several academic panels were presented by experts and doctors. According to the participants, these new discussions will help to find new drugs and treatments in the future.
Awamedica is an Erbil-based pharmaceutical company that produces, distributes, and promotes a diverse array of premium-quality essential pharmaceuticals at accessible rates. These products are made available to patients through both public and private healthcare facilities, including hospitals, clinics, and pharmacies.
Four other Iraqi pharmaceutical companies are also participating in the conference, saying Iraq must strengthen its competitiveness in the medical field.
Launched in 2017, the ICPM event stands as a cornerstone in the UAE’s pharmaceutical and healthcare sector. Organized in collaboration with Ajman University, this annual event has emerged as one of the most significant gatherings in the region. The conference consistently draws attention from key stakeholders and experts in the field.
Annually, within the framework of the ICPM platform, professionals from the healthcare, pharmaceutical, biotechnical, and academic sectors, along with various decision-makers, convene to participate in discussions, cultivate new partnerships, conduct business, and devise solutions and strategies aimed at reshaping the pharmaceutical and healthcare sector in the Middle East.
“We have more than 200 types of [pharmacutical] products that are available from both the private and public sectors and we can distribute them throughout Iraq. We are proud to participate in this conference and be able to import our medicine alongside Arab and international companies,” Aram Mohammed, a doctor and marketing director of Awamedica, told Rudaw.
"Our goal at this conference is to be enrolled in the [Gulf] market, and we have sent supplements to Syria and Yemen, and other countries," Ruha Jarjish, a sales officer at Awamedica, told Rudaw.
In addition to exhibiting the products of the pharmaceutical companies, several academic panels were presented by experts and doctors. According to the participants, these new discussions will help to find new drugs and treatments in the future.
Awamedica is an Erbil-based pharmaceutical company that produces, distributes, and promotes a diverse array of premium-quality essential pharmaceuticals at accessible rates. These products are made available to patients through both public and private healthcare facilities, including hospitals, clinics, and pharmacies.
Four other Iraqi pharmaceutical companies are also participating in the conference, saying Iraq must strengthen its competitiveness in the medical field.
Launched in 2017, the ICPM event stands as a cornerstone in the UAE’s pharmaceutical and healthcare sector. Organized in collaboration with Ajman University, this annual event has emerged as one of the most significant gatherings in the region. The conference consistently draws attention from key stakeholders and experts in the field.
Annually, within the framework of the ICPM platform, professionals from the healthcare, pharmaceutical, biotechnical, and academic sectors, along with various decision-makers, convene to participate in discussions, cultivate new partnerships, conduct business, and devise solutions and strategies aimed at reshaping the pharmaceutical and healthcare sector in the Middle East.
Comments
Rudaw moderates all comments submitted on our website. We welcome comments which are relevant to the article and encourage further discussion about the issues that matter to you. We also welcome constructive criticism about Rudaw.
To be approved for publication, however, your comments must meet our community guidelines.
We will not tolerate the following: profanity, threats, personal attacks, vulgarity, abuse (such as sexism, racism, homophobia or xenophobia), or commercial or personal promotion.
Comments that do not meet our guidelines will be rejected. Comments are not edited – they are either approved or rejected.
Post a comment